Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4233 - 4240 of 12009 results
Supreme Court Clarifies Race Discrimination Claims Under 42 U.S.C. § 1981 Must Meet More Stringent “But-For” Causation Standard
April 17, 2020| Blog| Viewpoint
ML Strategies COVID-19 Insights Week In Review — April 17, 2020
April 17, 2020| Article| Viewpoint
TCPA Litigation Update — Circuit Split Deepens on What Constitutes an ATDS Under the TCPA
April 16, 2020| Article| Viewpoint
Monthly TCPA Digest — April 2020
April 16, 2020| Article| Viewpoint
Attorney Fees Denied by Federal Circuit Where Case Was Voluntarily Dismissed Without Prejudice
April 16, 2020| Blog| Viewpoint
Four Things to Know About Trump’s Executive Order on Hoarding of PPE
April 15, 2020| Blog| Viewpoint
It’s Time to Get Colorful: Federal Circuit Holds That Some Color Marks Can Be Inherently Distinctive
April 15, 2020| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|